Melanoma is the deadliest skin cancer. Representing 95% of all skin cancer’s deaths. Since 1970’s the incidence has increased 360%, leading to one person dying of melanoma every hour in Europe.
The two-step method of follow-up is known to be the best possible practice to early detect melanoma. Unfortunately, it usually implies using different manual devices, which consumes time and resources. It is moment to push technology further and liberate qualified specialists from capturing images, so they can focus on the important part: the diagnoses. This is the main reason why Dermavision Solutions has created Deviskan, a device capable of gathering both clinical and dermatoscopic images in a single procedure.
Dermatoscopic images of potential malignant are captured automatically to ease dermatologist’s diagnose.
DEVISKAN IS COMING OUT THIS 2023
Deviskan is designed to scan a patient reducing human intervention and therefore it has some benefits to stand out.
Dermavision Solutions S.L. ha sido beneficiaria de un Proyecto subvencionado por el CDTI con la colaboración del Ministerio de Ciencia e Innovación. Número de expediente SNEO-20201346